{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:53:56Z","timestamp":1763564036527,"version":"3.37.3"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210600","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T13:40:53Z","timestamp":1547559653000},"page":"e0210600","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-605X","authenticated-orcid":true,"given":"Xiaonian","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/17512433.2016.1254041","article-title":"A pharmacological overview of lamotrigine for the treatment of epilepsy","volume":"9","author":"VR Yasam","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref2","first-page":"242","article-title":"Lamotrigine pharmacokinetics: oral and i.v. infusion in man","volume":"26","author":"AWC Yuen","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007691-199610000-00001","article-title":"Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication","volume":"18","author":"TW May","year":"1996","journal-title":"Ther Drug Monit"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00498250902745082","article-title":"Variation in glucuronidation of lamotrigine in human liver microsomes","volume":"39","author":"UA Argikar","year":"2009","journal-title":"Xenobiotica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":"In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction","volume":"34","author":"A Rowland","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"ref6","first-page":"1166","article-title":"In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes","volume":"260","author":"J Magdalou","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.dmpk.2014.12.007","article-title":"Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy","volume":"30","author":"Q Wang","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13318-014-0247-0","article-title":"Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine","volume":"41","author":"A Reimers","year":"2016","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.01.016","article-title":"The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy","volume":"95","author":"MI Gulcebi","year":"2011","journal-title":"Epilepsy Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-014-1690-1","article-title":"Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China","volume":"70","author":"Y Chang","year":"2014","journal-title":"European Journal of Clinical Pharmacology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.dmpk.2014.12.007","article-title":"Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinesechildren with epilepsy","volume":"30","author":"Q Wang","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cca.2014.09.004","article-title":"Effect of comedication on lamotrigine clearance in Korean epilepsy patients","volume":"438","author":"HJ Kim","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug comedication on lamotrigine clearance","volume":"62","author":"D Weintraub","year":"2005","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1157.1999.tb00832.x","article-title":"The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction","volume":"40","author":"F Pisani","year":"1999","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00007691-199904000-00007","article-title":"Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study","volume":"21","author":"TW May","year":"1999","journal-title":"Ther Drug Monit"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40262-017-0614-5","article-title":"Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials","volume":"57","author":"SC van Dijkman","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00007691-199712000-00003","article-title":"Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy","volume":"19","author":"D Battino","year":"1997","journal-title":"Ther Drug Monit"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007691-199706000-00002","article-title":"The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response","volume":"19","author":"A Bartoli","year":"1997","journal-title":"Ther Drug Monit"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00007691-200106000-00006","article-title":"Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication","volume":"23","author":"D Battino","year":"2001","journal-title":"Ther Drug Monit"},{"key":"ref20","first-page":"105","article-title":"Pupulation pharmacokinetics of lamotrigine in Chinese children with epilepsy","volume":"10","author":"Shen Zhang","year":"2008","journal-title":"Chin J Contemp Pediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1528-1167.2007.01201.x","article-title":"Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy","volume":"48","author":"C Otoul","year":"2007","journal-title":"Epilepsia"},{"key":"ref22","first-page":"750","article-title":"In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam","volume":"25","author":"RW Nims","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/pgs.14.186","article-title":"SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy","volume":"16","author":"CL Ma","year":"2015","journal-title":"Pharmacogenomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-200424040-00001","article-title":"Overview of the clinical pharmacokinetics of oxcarbazepine","volume":"24","author":"G F","year":"2004","journal-title":"Clin Drug Investig"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1097\/00007691-199908000-00094","article-title":"Topiramate decreases lamotrigine concentrations","volume":"21","author":"W Wnuk","year":"1999","journal-title":"Therapeutic Drug Monitoring"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1528-1157.2002.37701.x","article-title":"Lack of an effect of topiramate on lamotrigine serum concentrations","volume":"43","author":"DJ Berry","year":"2002","journal-title":"Epilepsia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1528-1157.2003.64402.x","article-title":"Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients","volume":"44","author":"DR Doose","year":"2003","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17332","article-title":"A mechanistic approach to antiepileptic drug interactions","volume":"32","author":"GD Anderson","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"e0169974","DOI":"10.1371\/journal.pone.0169974","article-title":"Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model\u2014Phenytoin and Valproate, Lamotrigine and Valproate","volume":"12","author":"KD Taing","year":"2017","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","article-title":"Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy","volume":"57","author":"BE Gidal","year":"2003","journal-title":"Epilepsy Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03191157","article-title":"Lamotrigine and valproate pharmacokinetics interactions in epileptic patients","volume":"34","author":"M Lalic","year":"2009","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/bcp.12984","article-title":"Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters","volume":"82","author":"D Milosheska","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00228-015-1925-9","article-title":"Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children","volume":"71","author":"L Liu","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-014-1690-1","article-title":"Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China","volume":"70","author":"Y Chang","year":"2014","journal-title":"Eur J Clin Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:48:42Z","timestamp":1588967322000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210600"}},"subtitle":[],"editor":[{"given":"Emilio","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210600","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,1,15]]}}}